Q: I know tour not keen on this stock my average cost is 11.00 should I buy more hold or sell Thanks
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: What US companies would you suggest I look into for a growth portfolio.
Q: How material is Bird,s contract on lng project in Kitmat. I don’t have exposure to infrastructure. A while back I traded this stock and made money. My objective this time is for diversification and longer term hold. The divided also fits in nicely with my portfolio. Your opinion on it’s valuation.
Would you buy it or are there better opportunities in the industry? Opinion please. Thank you.
Would you buy it or are there better opportunities in the industry? Opinion please. Thank you.
Q: I sold my PBH in the mid 90s, and am wondering if I should buy it back now, or is QSR a better buy today. I would it hold fit or a few years. Which do you prefer today, and why?
Q: What is 5i's opinion on Quorum's Q3 results and how does it compare to analyst expectations?
Q: Please comment on Q1.
Q: Can you please comment about company’s growth? Would you buy it at current price level?
Thanks!
Thanks!
Q: Weed is trading near $20. Is it a interesting speculation near that price? Thanks for your previous advice on that stock; you saved me thousands of $.
-
Raytheon Company (RTN)
-
The Rubicon Project Inc. (RUBI)
-
The Trade Desk Inc. (TTD)
-
Guardant Health Inc. (GH)
Q: Since starting to do more and more of my own investing I have found your advice incredibly profitable! Thank you. I follow the Canadian balanced portfolio and try to add in some US growth names. I am also diversified into ETFs. Right now I have cash for 2 new US positions. I want to add growth positions and have a long long time frame. Currently considering GH, RTN and RUBI. Do you still like all three at current prices? And which would you choose? Any other suggestions?
Q: Hello Peter,
Medipharm labs reported a strong quarter and yet the stock took a tumble. Any comments please?
Medipharm labs reported a strong quarter and yet the stock took a tumble. Any comments please?
Q: Is there currently a stock that 5I considers a "screaming buy" in Canada or the US for a short or long term hold.
Thanks Valter
Thanks Valter
Q: Hi,
I have a 1% starter position in Goose. I was holding off on adding till after they reported. Would you add now during this pull back? Is the growth story still intact?
Thanks,
Kerri
I have a 1% starter position in Goose. I was holding off on adding till after they reported. Would you add now during this pull back? Is the growth story still intact?
Thanks,
Kerri
Q: Just to polish off the answer to Adam's question on GOOS, what do you reccomend to those holding the stock given all of the new info brought to light?
Sheldon
Sheldon
Q: GOOS looked to have a good quarter, reiterated guidance, was trading higher in pre-markets this morning and now is getting hammered. Obviously I missed something... Where do you see GOOS going from here and what is dragging it down today?
Thanks!
Thanks!
Q: Can you please comment on results and company going forward. Thanks
Q: Hi 5i Team
Are there two or three US companies that are poised for huge growth in the near future? Thanks!
Are there two or three US companies that are poised for huge growth in the near future? Thanks!
Q: Your thoughts on their 1/4 please, thanks
Q: I read the most recent press release from DIRRT Environmental on their 3rd quarter release. The CEO Kevin O'Meara made some pretty pointed comments about the company's failure to execute. I have never heard a CEO publically give such a frank and honest assessment of the company's missteps. Is Mr O'Meara a one off or is his rant a normal response from an unhappy CEO
Q: Many on your tax-loss list show estimated revenue growth > 100%; in more than a few cases, > 200%. In the case of marijuana stocks, this is puzzling, as many argue that prices will continue to weaken.
On what basis, then, should we place confidence in these numbers? Take HEXO, which you observed (last August) was priced at 4X forward sales, has since then declined by 45%, but is estimating revenue growth at 280%: what would it take to find its prospects 'interesting'?
On what basis, then, should we place confidence in these numbers? Take HEXO, which you observed (last August) was priced at 4X forward sales, has since then declined by 45%, but is estimating revenue growth at 280%: what would it take to find its prospects 'interesting'?
Q: comment on earnings. They appear to be "ok", but market seems quite pleased. Can you comment on them and why market is positive. I also feel the PE isn't overly attractive.